Bawei Chenxiang Wan Ameliorates Cardiac Hypertrophy by Activating AMPK/PPAR- α Signaling Pathway Improving Energy Metabolism
In conclusion, BCW prevents ISO-induced cardiomyocyte hypertrophy by activating AMPK/PPAR-α to alleviate the disturbance in energy metabolism. Therefore, BCW can be used as an alternative drug for the treatment of cardiac hypertrophy.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | China Health | Drugs & Pharmacology | Genetics | Heart | Mitochondria | Mitochondrial Disease | Study